De novo isolation of antibodies with pH-dependent binding properties

mAbs

Volumn 7, Issue 2, 2015, Pages 294-302

  Bonvin, Pauline ^a   Venet, Sophie ^a   Fontaine, Gaëlle ^a   Ravn, Ulla ^a   Gueneau, Franck ^a   Kosco Vilbois, Marie ^a   Proudfoot, Amanda E I ^a   Fischer, Nicolas ^a  

^a NOVIMMUNE SA   (Switzerland)

Author keywords

Antibody recycling; Chemokine; Histidine; Monoclonal antibody; PH dependency; Phage display; Phage libraries

Indexed keywords

ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTIDINE; CXCL10 PROTEIN, HUMAN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ACIDITY; ANTIBODY ENGINEERING; ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CLONE; PH; PHAGE DISPLAY; CHEMISTRY; GENETICS; HUMAN; PROTEIN ENGINEERING;

CHEMOKINE CXCL10; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN ENGINEERING; SINGLE-CHAIN ANTIBODIES;

EID: 84924590008     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.1080/19420862.2015.1006993     Document Type: Article

References (39)

1. Yagami H, Kato H, Tsumoto K, Tomita M. Monoclonal antibodies based on hybridoma technology. Pharm Pat Anal 2013; 2:249-63; http://dx.doi.org/10.4155/ ppa.13.2
2. Hairul Bahara NH, Tye GJ, Choong YS, Ong EB, Ismail A, Lim TS. Phage display antibodies for diagnostic applications. Biologicals 2013; 41:209-16; PMID:23647952; http://dx.doi.org/10.1016/j. biologicals.2013.04.001
3. Vincent KJ, Zurini M. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates. Biotechnol J 2012; 7:1444-50; PMID:23125076; http://dx.doi.org/10.1002/biot. 201200250
4. Sela-Culang I, Kunik V, Ofran Y. The structural basis of antibody-antigen recognition. Front Immunol 2013; 4:302; PMID:24115948; http://dx.doi.org/10.3389/ fimmu.2013.00302
5. Aggarwal RS. What's fueling the biotech engine-2012 to 2013. Nat Biotechnol 2014; 32:32-39; PMID:24406926; http://dx.doi.org/10.1038/nbt.2794
6. Campbell AM. ed. Monoclonal antibody technology: the production and characterization of rodent and human hybridomas. New York: Elsevier Science Ltd; 1984.
7. Zeng X, Shen Z, Mernaugh R. Recombinant antibodies and their use in biosensors. Anal Bioanal Chem 2012; 402:3027-38; http://dx.doi.org/10.1007/s00216-011- 5569-z
8. Deb R, Chakraborty S, Veeregowda B, Veram A, Tiwari R, Dhama K. Monoclonal antibody and its use in the diagnosis of livestock diseases. Adv Biosci Biotechnol 2013; 50-62; http://dx.doi.org/10.4236/ abb.2013.44A008
9. Moser AC, Hage DS. Immunoaffinity chromatography: an introduction to applications and recent developments. Bioanalysis 2010; 2:769-90; PMID:20640220; http://dx.doi.org/10.4155/bio.10.31
10. Tomomori-Sato C, Sato S, Conaway RC, Conaway JW. Immunoaffinity purification of protein complexes from Mammalian cells. Methods Mol Biol 2013; 977:273-87; PMID:23436370; http://dx.doi.org/ 10.1007/978-1-62703-284-1-22
11. Davoli E, Fanelli R, Bagnati R. Purification and analysis of drug residues in urine samples by on-line immunoaffinity chromatography/high-performance liquid chromatography/continuous-flow fast atom bombardment mass spectrometry. Anal.Chem. 1993; 65:2679-85.
12. Jorge I, Burillo E, Mesa R, Baila-Rueda L, Moreno M, Trevisan-Herraz M, Silla-Castro JC, Camafeita E, Ortega-Munoz M, Bonzon-Kulichenko E, et al. The human HDL proteome displays high inter-individual variability and is altered dynamically in response to angioplasty-induced atheroma plaque rupture. J Proteomics 2014; 106:61-73; PMID:24747125; http://dx. doi.org/10.1016/j.jprot.2014.04.010
13. Ehle H, Horn A. Immunoaffinity chromatography of enzymes. Bioseparation 1990; 1:97-110; PMID:1368167
14. Luppa PB, Sokoll LJ, Chan DW. Immunosensors- principles and applications to clinical chemistry. Clin Chim Acta 2001; 314:1-26.
15. Gonzalez-Martinez MA, Puchades R, Maquieira A. Optical immunosensors for environmental monitoring: how far have we come? Anal Bioanal Chem 2007; 387:205-18; PMID:17072601; http://dx.doi.org/ 10.1007/s00216-006-0849-8
16. Ricci F, Volpe G, Micheli L, Palleschi G. A review on novel developments and applications of immunosensors in food analysis. Anal Chim Acta 2007; 605: 111-29; PMID:18036374; http://dx.doi.org/10.1016/ j.aca.2007.10.046
17. Goding JW. ed. Monoclonal antibodies: principles and practice. London: Academic Press; 1986.
18. Chakraborty A, Van LM, Skerjanec A, Floch D, Klein UR, Krammer G, Sunkara G, Howard D. Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis. J Clin Pharmacol 2013; 53:1240-51; PMID:24122883; http://dx.doi.org/ 10.1002/jcph.162
19. Fetterly GJ, Aras U, Meholick PD, Takimoto C, Seetharam S, McIntosh T, de Bono JS, Sandhu SK, Tolcher A, Davis HM, et al. Utilizing pharmacokinetics/ pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. J Clin Pharmacol 2013; 53:1020-7; PMID:23878055; http://dx.doi.org/ 10.1002/jcph.140
20. Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, et al. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum. 2006; 54:2387-92; PMID:16869001; http://dx.doi.org/10.1002/art.21975
21. Siemers ER, Friedrich S, Dean RA, Gonzales CR, Farlow MR, Paul SM, Demattos RB. Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease. Clin Neuropharmacol 2010; 33:67-73; PMID:20375655; http://dx.doi.org/10.1097/WNF.0b013e3181cb577a
22. Xiao JJ, Krzyzanski W, Wang YM, Li H, Rose MJ, Ma M, Wu Y, Hinkle B, Perez-Ruixo JJ. Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys. AAPS J 2010; 12:646-57; PMID:20737261; http://dx.doi.org/ 10.1208/s12248-010-9222-0
23. Giragossian C, Clark T, Piche-Nicholas N, Bowman CJ. Neonatal Fc receptor and its role in the absorption, distribution, metabolism and excretion of immunoglobulin G-based biotherapeutics. Curr Drug Metab 2013; 14:764-90; PMID:23952252; http://dx.doi.org/ 10.2174/13892002113149990099
24. Igawa T, Mimoto F, Hattori K. pH-dependent anti-gen- binding antibodies as a novel therapeutic modality. Biochim Biophys Acta 2014; http://dx.doi.org/ 10.1016/j.bbapap.2014.08.003; PMID:25125373
25. Igawa T, Ishii S, Tachibana T, Maeda A, Higuchi Y, Shimaoka S, Moriyama C, Watanabe T, Takubo R, Doi Y, et al. Antibody recycling by engineered pHdependent antigen binding improves the duration of antigen neutralization. Nat Biotechnol 2010; 28: 1203-7; PMID:20953198; http://dx.doi.org/10.1038/ nbt.1691
26. Chaparro-Riggers J, Liang H, DeVay RM, Bai L, Sutton JE, Chen W, Geng T, Lindquist K, Casas MG, Boustany LM, et al. Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9. J Biol Chem 2012; 287:11090-7; PMID:22294692; http:// dx.doi.org/10.1074/jbc.M111.319764
27. Devanaboyina SC, Lynch SM, Ober RJ, Ram S, Kim D, Puig-Canto A, Breen S, Kasturirangan S, Fowler S, Peng L, et al. The effect of pH dependence of anti-body- antigen interactions on subcellular trafficking dynamics. MAbs. 2013; 5:851-9; PMID:24492341; http://dx.doi.org/10.4161/mabs.26389
28. Stryer L, Berg JM, Tymoczko JL. ed. Biochemistry. New York: W.H. Freeman; 2002.
29. Sarkar CA, Lowenhaupt K, Horan T, Boone TC, Tidor B, Lauffenburger DA. Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching". Nat Biotechnol 2002; 20:908-13; PMID:12161759; http://dx.doi.org/ 10.1038/nbt725
30. Igawa T, Maeda A, Haraya K, Tachibana T, Iwayanagi Y, Mimoto F, Higuchi Y, Ishii S, Tamba S, Hironiwa N, et al. Engineered monoclonal antibody with novel antigen-sweeping activity in vivo. PLoS One 2013; 8: e63236; PMID:23667591; http://dx.doi.org/10.1371/ journal.pone.0063236
31. Murtaugh ML, Fanning SW, Sharma TM, Terry AM, Horn JR. A combinatorial histidine scanning library approach to engineer highly pH-dependent protein switches. Protein Sci. 2011; 20:1619-31; PMID:21766385; http://dx.doi.org/10.1002/pro.696
32. Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW Jr, Kirkham PM. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol.Biol. 2003; 334:733-49; http://dx.doi.org/ 10.1016/j.jmb.2003.10.007
33. Venet S. Human antibody libraries capturing purpose oriented CDRH3 repertoires; dissertation. Lausanne (Switzerland): Ecole Polytechnique F-ed-erale de Lausanne; 2013; 97-98.
34. Fellouse FA, Li B, Compaan DM, Peden AA, Hymowitz SG, Sidhu SS. Molecular recognition by a binary code. J Mol Biol 2005; 348:1153-62; PMID:15854651; http://dx.doi.org/10.1016/j.jmb. 2005.03.041
35. Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L, Thouvenin-Contet V, Lefranc G. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily Vlike domains. Dev Comp Immunol 2003; 27:55-77; PMID:12477501; http://dx.doi.org/10.1016/S0145-305X(02)00039-3
36. Honegger A, Pluckthun A. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. J Mol Biol 2001; 309:657-70; PMID:11397087; http://dx.doi.org/ 10.1006/jmbi.2001.4662
37. Ignatovich O, Jespers L, Tomlinson IM, de Wildt RM. Creation of the large and highly functional synthetic repertoire of human VH and Vkappa domain antibodies. Methods Mol Biol 2012; 911:39-63; PMID:22886245; http://dx.doi.org/10.1007/978-1- 61779-968-6-4
38. Salanga CL, Handel TM. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res 2011; 317:590-601; PMID:21223963; http:// dx.doi.org/10.1016/j.yexcr.2011.01.004
39. Rich RL, Myszka DG. Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'. J Mol Recognit 2010; 23:1-64; PMID:20017116; http://dx.doi.org/10.1002/jmr.1004